[Takotsubo cardiomyopathy: a novel beta-adrenergic blocker withdrawal syndrome]
| Autor: | Vince Wagner, Kinga Jávor, András Zsoldos, Hrisula Arabadzisz, Balázs Sármán, János Tomcsányi |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
medicine.medical_specialty
medicine.drug_class Adrenergic beta-Antagonists Cardiomyopathy Angiotensin-Converting Enzyme Inhibitors Coronary artery disease Drug withdrawal Electrocardiography Heart Conduction System Takotsubo Cardiomyopathy Internal medicine medicine Bisoprolol Humans Beta blocker Carvedilol Aged Beta-adrenergic blocking agent business.industry Arrhythmias Cardiac General Medicine medicine.disease Adrenergic beta-1 Receptor Antagonists Discontinuation Substance Withdrawal Syndrome Echocardiography Anesthesia Cardiology Female business medicine.drug |
| Zdroj: | Orvosi hetilap. 154(7) |
| ISSN: | 0030-6002 |
| Popis: | The authors describe two cases of takotsubo cardiomyopathy developing after an abrupt withdrawal of carvedilol and bisoprolol. Takotsubo or stress cardiomyopathy is characterized by acute and reversible cardiac dysfunction without coronary artery disease. It is triggered by acute emotional or physical stress, drugs or drug withdrawal. The immediate discontinuation of the long acting vasodilator beta-blocker, carvedilol has not yet been described to cause takotsubo cardiomyopathy. The authors recommend cautious withdrawal of beta-blockers. Orv. Hetil., 2013, 154, 267–271. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|